Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
BIOMARIN PHARMACEUTICAL INC | President, Worldwide R&D | Common Stock | 196,872 | $16.5 M | $83.87 | Mar 15, 2024 | Direct |
Mirati Therapeutics, Inc. | Director | Common Stock | 10,465 | $618 K | $59.02 | Jan 20, 2023 | Direct |
BIOMARIN PHARMACEUTICAL INC | President, Worldwide R&D | Stock Option (Right to Buy Common Stock) | 40,860 | Mar 15, 2024 | Direct | ||
Mirati Therapeutics, Inc. | Director | Non Qualified Stock Option (right to buy) | 7,520 | Jan 20, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
BMRN | BIOMARIN PHARMACEUTICAL INC | Mar 15, 2024 | 3 | -2,808,387 | 4 | Mar 19, 2024 | President, Worldwide R&D |
BMRN | BIOMARIN PHARMACEUTICAL INC | Mar 5, 2024 | 1 | -3,010,396 | 4 | Mar 7, 2024 | President, Worldwide R&D |
BMRN | BIOMARIN PHARMACEUTICAL INC | Feb 27, 2024 | 3 | 0 | 4 | Feb 29, 2024 | President, Worldwide R&D |
BMRN | BIOMARIN PHARMACEUTICAL INC | Dec 1, 2023 | 2 | 21,200 | 4 | Dec 5, 2023 | President, Worldwide R&D |
BMRN | BIOMARIN PHARMACEUTICAL INC | Aug 10, 2023 | 1 | -1,085,111 | 4 | Aug 11, 2023 | President, Worldwide R&D |
BMRN | BIOMARIN PHARMACEUTICAL INC | Mar 15, 2023 | 4 | -3,783,824 | 4 | Mar 17, 2023 | President, Worldwide R&D |
BMRN | BIOMARIN PHARMACEUTICAL INC | Feb 28, 2023 | 3 | 0 | 4 | Mar 2, 2023 | President, Worldwide R&D |
MRTX | Mirati Therapeutics, Inc. | Jan 20, 2023 | 2 | 0 | 4 | Jan 24, 2023 | Director |
BMRN | BIOMARIN PHARMACEUTICAL INC | Dec 31, 2022 | 1 | 21,281 | 5 | Feb 10, 2023 | President, Worldwide R&D |
BMRN | BIOMARIN PHARMACEUTICAL INC | Mar 15, 2022 | 4 | -1,129,492 | 4 | Mar 17, 2022 | President, Worldwide R&D |
BMRN | BIOMARIN PHARMACEUTICAL INC | Mar 8, 2022 | 1 | 0 | 4 | Mar 10, 2022 | President, Worldwide R&D |
MRTX | Mirati Therapeutics, Inc. | Feb 11, 2022 | 7 | -935,777 | 4 | Feb 14, 2022 | Director |
MRTX | Mirati Therapeutics, Inc. | Jan 14, 2022 | 2 | 0 | 4 | Jan 18, 2022 | Director |
BMRN | BIOMARIN PHARMACEUTICAL INC | Dec 31, 2021 | 1 | 21,281 | 5 | Feb 11, 2022 | President, Worldwide R&D |